COMPLEX INTRACELLULAR SIGNAL-TRANSDUCTION REGULATES TISSUE-PLASMINOGEN ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) SYNTHESIS IN CULTURED HUMAN UMBILICAL VEIN ENDOTHELIUM

被引:20
|
作者
RYDHOLM, H
BOSTROM, S
ERIKSSON, E
RISBERG, B
机构
[1] LUND UNIV, MALMO GEN HOSP, DEPT SURG, LUND, SWEDEN
[2] ASTRA HASSLE AB, MOLNDAL, SWEDEN
关键词
CAMP; CGMP; ENDOTHELIAL CELL; ENDOTHELIN; ENDOTOXIN; PLASMINOGEN; ACTIVATOR INHIBITOR; PROTEIN KINASE C; REGULATION; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;
D O I
10.3109/00365519509104970
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Endothelial cells are central in fibrinolysis because of their high production of both activators (t-PA, uPA) and inhibitors (PAI-1). The t-PA and PAI-1 synthesis could be regulated by signals transduction at several cellular levels. The purpose of this in vitro study, on cultured endothelial cells, was to explore the receptor/second messenger regulation of the t-PA and PAI-1 synthesis. Quiescent confluent human umbilical vein endothelial cells, cultured in passage 1, were exposed to different test substances. Samples from the conditioned medium were collected after 16 and 24 h and analysed for t-PA and PAI-1 antigen. All data presented were related to the data from control dishes (=100%), in the same experiment. The results from the present study (mean +/-95% confidence interval) demonstrated the following. (1) Forskolin, with a documented direct cAMP-inducing effect, decreased the basal PAI-1 production to 61+/-15%, and Na-nitroprusside, with a documented cGMP-inducing effect, increased the basal PAI-1 production to 141+/-38% without affecting the basal t-PA production. The surface receptor agonists isoprenalin or ephedrine, which indirectly affect adenylate cyclase, had no effect on t-PA or PAI-1 production. (2) Phorbolester (PMA), which directly activates proteinkinase C (PKC), increased the basal t-PA and PAI-1 production to 350+/-71%, and 163+/-35% respectively. (3) Thrombin, but not endothelin-1 (ET-1), increased the basal t-PA and PAI-1 production to 195+/-34% and 136+/-18%, respectively, indicating an PKC-mediated thrombin effect. (4) Endotoxin increased both the basal t-PA and PAI-1 production to 130+/-20% and 136+/-30%, respectively. These data indicated that various stimuli involve different pathways e.g. cAMP, cGMP and PKC. Pharmacological interference with the regulation of t-PA and PAI-1 must take this complexity into account.
引用
收藏
页码:323 / 330
页数:8
相关论文
共 50 条
  • [1] TISSUE-PLASMINOGEN ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) IN VARIOUS DISEASE STATES
    KOTSCHY, M
    ROSC, D
    KOTSCHY, D
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1139 - 1139
  • [2] INTERACTION OF PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) AND TISSUE PLASMINOGEN-ACTIVATOR (T-PA) ON FIBRIN
    WAGNER, OF
    HOHMANN, C
    VEERMAN, H
    DEVRIES, C
    VOORN, P
    LAMBERS, H
    KLEINGEBBINK, R
    EHRLICH, HJ
    PANNEKOEK, H
    BLUT, 1988, 57 (04): : 184 - 184
  • [3] Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue-plasminogen activator (t-PA) activity in patients with Noonan syndrome
    Metha, P
    Parker, RL
    Galvin-Parton, P
    Wilson, TA
    Prakash, D
    PEDIATRIC RESEARCH, 2002, 51 (04) : 250A - 250A
  • [5] EFFECT OF DEXTRAN ON PLASMA TISSUE-PLASMINOGEN ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) DURING SURGERY
    ERIKSSON, M
    SALDEEN, T
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1995, 39 (02) : 163 - 166
  • [6] MOLECULAR-FORMS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) IN HUMAN PLASMA
    ALESSI, MC
    JUHANVAGUE, I
    DECLERCK, PJ
    COLLEN, D
    THROMBOSIS RESEARCH, 1991, 62 (04) : 275 - 285
  • [7] TISSUE-PLASMINOGEN ACTIVATOR (TPA), PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1(PAI-1) IN DIABETIC PREGNANT-WOMEN
    BRONISZ, A
    KOTSCHY, M
    ROSC, D
    GRACZYKOWSKAKOCZOROWSKA, A
    DREWNIAK, W
    DIABETOLOGIA, 1995, 38 : A285 - A285
  • [8] Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) in diabetic foot syndrome
    Kulwas, Arleta
    Lisewska, Beata
    Jundzill, Wieslaw
    Ruszkowska, Barbara
    Drewniak, Wanda
    Ruprecht, Zofia
    Gadomska, Grazyna
    Rosc, Danuta
    ADVANCES IN MEDICAL SCIENCES, 2017, 62 (01): : 87 - 91
  • [9] THE RECEPTOR FOR TISSUE PLASMINOGEN-ACTIVATOR (T-PA) IN COMPLEX WITH ITS INHIBITOR, PAI-1, ON HUMAN HEPATOCYTES
    WING, LR
    BENNETT, B
    BOOTH, NA
    FEBS LETTERS, 1991, 278 (01): : 95 - 97
  • [10] EFFECT OF DEXTRAN ON PLASMA TISSUE PLASMINOGEN-ACTIVATOR (T-PA) AND TISSUE PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) DURING SURGERY
    ERIKSSON, M
    SALDEEN, T
    WALLIN, R
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 394 - 394